ATARA BIOTHERAPEUTICS, INC. Accretion Expense
ATARA BIOTHERAPEUTICS, INC. (ATRA) reported Accretion Expense of $987.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:AccretionExpense · last filed 2026-08-12
- ATARA BIOTHERAPEUTICS, INC. accretion expense for the quarter ending 2026-06-30 was $173.00K, a 81.92% decline year-over-year.
- ATARA BIOTHERAPEUTICS, INC. accretion expense for the quarter ending 2026-03-31 was $814.00K, a 4.46% decline year-over-year.
- ATARA BIOTHERAPEUTICS, INC. accretion expense for the quarter ending 2025-12-31 was $878.00K, a 5.49% decline year-over-year.
- ATARA BIOTHERAPEUTICS, INC. accretion expense for the quarter ending 2025-09-30 was $891.00K, a 18.03% decline year-over-year.
- ATARA BIOTHERAPEUTICS, INC. accretion expense for fiscal 2025 was $3.58M, a 12.92% decline from fiscal 2024.
- ATARA BIOTHERAPEUTICS, INC. accretion expense for fiscal 2024 was $4.11M, a 14.25% decline from fiscal 2023.
- ATARA BIOTHERAPEUTICS, INC. accretion expense for fiscal 2023 was $4.79M.
- ATARA BIOTHERAPEUTICS, INC. accretion expense for fiscal 2022 was $0.00, a 100.00% decline from fiscal 2021.
| Period end | Accretion Expense 3 month | Accretion Expense 3 month as first filed | Accretion Expense 6 month | Accretion Expense 6 month as first filed | Accretion Expense 9 month | Accretion Expense 9 month as first filed | Accretion Expense 12 month |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | $173.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-12 | $987.00K 10-Q · filed 2026-08-12 | $1.86M derived: sum of 3 quarters · filed 2026-08-12 | $2.76M derived: sum of 4 quarters · filed 2026-08-12 | |||
| 2026-03-31 | $814.00K 10-Q · filed 2026-05-12 | $1.69M derived: sum of 2 quarters · filed 2026-05-12 | $2.58M derived: sum of 3 quarters · filed 2026-05-12 | $3.54M derived: sum of 4 quarters · filed 2026-08-12 | |||
| 2025-12-31 | $878.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-16 | $1.77M derived: sum of 2 quarters · filed 2026-03-16 | $2.73M derived: sum of 3 quarters · filed 2026-08-12 | $3.58M 10-K · filed 2026-03-16 | |||
| 2025-09-30 | $891.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | $1.85M derived: sum of 2 quarters · filed 2026-08-12 | $2.70M 10-Q · filed 2025-11-12 | $3.63M derived: sum of 4 quarters · filed 2026-08-12 | |||
| 2025-06-30 | $957.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-12 | $1.81M 10-Q · filed 2026-08-12 | $2.74M derived: sum of 3 quarters · filed 2026-08-12 | $3.83M derived: sum of 4 quarters · filed 2026-08-12 | |||
| 2025-03-31 | $852.00K 10-Q · filed 2026-05-12 | $1.78M derived: sum of 2 quarters · filed 2026-05-12 | $2.87M derived: sum of 3 quarters · filed 2026-05-12 | $3.92M derived: sum of 4 quarters · filed 2026-05-12 | |||
| 2024-12-31 | $929.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-16 | $2.02M derived: sum of 2 quarters · filed 2026-03-16 | $3.06M derived: sum of 3 quarters · filed 2026-03-16 | $4.11M 10-K · filed 2026-03-16 | |||
| 2024-09-30 | $1.09M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | $2.13M derived: sum of 2 quarters · filed 2025-11-12 | $3.18M 10-Q · filed 2025-11-12 | $4.24M derived: sum of 4 quarters · filed 2025-11-12 | |||
| 2024-06-30 | $1.05M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-11 | $2.09M 10-Q · filed 2025-08-11 | $3.16M derived: sum of 3 quarters · filed 2025-08-11 | $4.43M derived: sum of 4 quarters · filed 2025-08-11 | |||
| 2024-03-31 | $1.05M 10-Q · filed 2025-05-15 | $2.11M derived: sum of 2 quarters · filed 2025-05-15 | $3.38M derived: sum of 3 quarters · filed 2025-05-15 | $4.63M derived: sum of 4 quarters · filed 2025-05-15 | |||
| 2023-12-31 | $1.06M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-07 | $2.34M derived: sum of 2 quarters · filed 2025-03-07 | $3.59M derived: sum of 3 quarters · filed 2025-03-07 | $4.79M 10-K · filed 2025-03-07 | |||
| 2023-09-30 | $1.27M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | $2.52M derived: sum of 2 quarters · filed 2024-11-12 | $3.73M 10-Q · filed 2024-11-12 | $3.73M derived: sum of 4 quarters · filed 2024-11-12 | |||
| 2023-06-30 | $1.25M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-12 | $2.46M 10-Q · filed 2024-08-12 | $2.46M derived: sum of 3 quarters · filed 2024-08-12 | $2.46M derived: sum of 4 quarters · filed 2024-08-12 | |||
| 2023-03-31 | $1.20M 10-Q · filed 2024-05-09 | $1.20M derived: sum of 2 quarters · filed 2024-05-09 | $1.20M derived: sum of 3 quarters · filed 2024-05-09 | $1.20M derived: sum of 4 quarters · filed 2024-05-09 | |||
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-28 | $0.00 derived: sum of 2 quarters · filed 2024-03-28 | $0.00 derived: sum of 3 quarters · filed 2024-03-28 | $0.00 10-K · filed 2024-03-28 | |||
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-01 | $0.00 derived: sum of 2 quarters · filed 2023-11-01 | $0.00 10-Q · filed 2023-11-01 | $70.00K 10-Q · filed 2022-11-08 | $23.00K derived: sum of 4 quarters · filed 2023-11-01 | ||
| 2022-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-08 | $0.00 10-Q · filed 2023-08-08 | $46.00K 10-Q · filed 2022-08-08 | $23.00K derived: sum of 3 quarters · filed 2023-08-08 | $44.00K derived: sum of 4 quarters · filed 2023-08-08 | ||
| 2022-03-31 | $0.00 10-Q · filed 2023-05-08 | $7.00K 10-Q · filed 2022-05-05 | $23.00K derived: sum of 2 quarters · filed 2023-05-08 | $44.00K derived: sum of 3 quarters · filed 2023-05-08 | $66.00K derived: sum of 4 quarters · filed 2023-05-08 | ||
| 2021-12-31 | $23.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-28 | $44.00K derived: sum of 2 quarters · filed 2022-11-08 | $66.00K derived: sum of 3 quarters · filed 2022-11-08 | $87.00K 10-K · filed 2022-02-28 | |||
| 2021-09-30 | $21.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-08 | $43.00K derived: sum of 2 quarters · filed 2022-11-08 | $64.00K 10-Q · filed 2022-11-08 | $84.00K derived: sum of 4 quarters · filed 2022-11-08 | |||
| 2021-06-30 | $22.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-08 | $43.00K 10-Q · filed 2022-08-08 | $63.00K derived: sum of 3 quarters · filed 2022-08-08 | $83.00K derived: sum of 4 quarters · filed 2022-08-08 | |||
| 2021-03-31 | $21.00K 10-Q · filed 2022-05-05 | $41.00K derived: sum of 2 quarters · filed 2022-05-05 | $61.00K derived: sum of 3 quarters · filed 2022-05-05 | $80.00K derived: sum of 4 quarters · filed 2022-05-05 | |||
| 2020-12-31 | $20.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-28 | $40.00K derived: sum of 2 quarters · filed 2022-02-28 | $59.00K derived: sum of 3 quarters · filed 2022-02-28 | $78.00K 10-K · filed 2022-02-28 | |||
| 2020-09-30 | $20.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-04 | $39.00K derived: sum of 2 quarters · filed 2021-11-04 | $58.00K 10-Q · filed 2021-11-04 | $76.00K derived: sum of 4 quarters · filed 2022-02-28 | |||
| 2020-06-30 | $19.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-09 | $38.00K 10-Q · filed 2021-08-09 | $56.00K derived: sum of 3 quarters · filed 2022-02-28 | $74.00K derived: sum of 4 quarters · filed 2022-02-28 | |||
| 2020-03-31 | $19.00K 10-Q · filed 2021-05-04 | $37.00K derived: sum of 2 quarters · filed 2022-02-28 | $55.00K derived: sum of 3 quarters · filed 2022-02-28 | $73.00K derived: sum of 4 quarters · filed 2022-02-28 | |||
| 2019-12-31 | $18.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-28 | $36.00K derived: sum of 2 quarters · filed 2022-02-28 | $54.00K derived: sum of 3 quarters · filed 2022-02-28 | $71.00K 10-K · filed 2022-02-28 | |||
| 2019-09-30 | $18.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-09 | $36.00K derived: sum of 2 quarters · filed 2020-11-09 | $53.00K 10-Q · filed 2020-11-09 | $70.00K derived: sum of 4 quarters · filed 2021-03-01 | |||
| 2019-06-30 | $18.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-05 | $35.00K 10-Q · filed 2020-08-05 | $52.00K derived: sum of 3 quarters · filed 2021-03-01 | $68.00K derived: sum of 4 quarters · filed 2021-03-01 | |||
| 2019-03-31 | $17.00K 10-Q · filed 2020-05-06 | $34.00K derived: sum of 2 quarters · filed 2021-03-01 | $50.00K derived: sum of 3 quarters · filed 2021-03-01 | $66.00K derived: sum of 4 quarters · filed 2021-03-01 | |||
| 2018-12-31 | $17.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-01 | $33.00K derived: sum of 2 quarters · filed 2021-03-01 | $49.00K derived: sum of 3 quarters · filed 2021-03-01 | $49.00K 10-K · filed 2021-03-01 | |||
| 2018-09-30 | $16.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-07 | $32.00K derived: sum of 2 quarters · filed 2019-11-07 | $32.00K 10-Q · filed 2019-11-07 | $32.00K derived: sum of 4 quarters · filed 2020-02-27 | |||
| 2018-06-30 | $16.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-08 | $16.00K 10-Q · filed 2019-08-08 | $16.00K derived: sum of 3 quarters · filed 2020-02-27 | $16.00K derived: sum of 4 quarters · filed 2020-02-27 | |||
| 2018-03-31 | $0.00 10-Q · filed 2019-05-09 | $0.00 derived: sum of 2 quarters · filed 2020-02-27 | $0.00 derived: sum of 3 quarters · filed 2020-02-27 | ||||
| 2017-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-27 | $0.00 derived: sum of 2 quarters · filed 2020-02-27 | $0.00 10-K · filed 2020-02-27 | ||||
| 2017-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-06 | $0.00 10-Q · filed 2018-11-06 | |||||
| 2017-06-30 | $0.00 10-Q · filed 2018-08-01 | ||||||
| 2016-12-31 | $0.00 10-K · filed 2019-02-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Pelthos Therapeutics Inc. (PTHS) | United States | $0.086B | -1.20 |
| COGNITION THERAPEUTICS INC (CGTX) | United States | $0.090B | -6.52 |
| Vaxart, Inc. (VXRT) | United States | $0.080B | 3.84 |
| Kalaris Therapeutics, Inc. (KLRS) | United States | $0.073B | -2.19 |
| Cardiff Oncology, Inc. (CRDF) | United States | $0.101B | -2.22 |
| CHAMPIONS ONCOLOGY, INC. (CSBR) | United States | $0.070B | -68.02 |
| BioStem Technologies, Inc. (BSEM) | United States | $0.069B | |
| Eloxx Pharmaceuticals, Inc. (ELOX) | United States | $0.065B | |
| Black Diamond Therapeutics, Inc. (BDTX) | United States | $0.109B | -2.48 |
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |